论文部分内容阅读
甲胎蛋白（ＡＦＰ）是临床诊断原发性肝癌（ＰＨＣ）的主要血清学指标。但是，我国约有１０％～３０％的ＰＨＣ病人血清中ＡＦＰ呈低水平表达［１］。为此，许多学者致力于寻找其他肿瘤标志物，来弥补ＡＦＰ的这一不足。现发现ａ－Ｌ－岩藻糖苷酶（ＡＦＵ）与ＡＦＰ联合检测可?
Alpha-fetoprotein (AFP) is the main serological marker for clinical diagnosis of primary liver cancer (PHC). However, approximately 10% to 30% of PHC patients in China have low levels of AFP in serum [1]. For this reason, many scholars are committed to finding other tumor markers to compensate for this deficiency of AFP. A-L-fucosidase (AFU) and AFP combined detection can be found?